Host conditioning with total lymphoid irradiation and antithymocyte globulin prevents graft-versus-host disease: the role of CD1-reactive natural killer.

Slides:



Advertisements
Similar presentations
Joseph H. Chewning, Weiwei Zhang, David A. Randolph, C
Advertisements

Reduced Graft-versus-Host Disease in C3-Deficient Mice Is Associated with Decreased Donor Th1/Th17 Differentiation  Qing Ma, Dan Li, Roza Nurieva, Rebecca.
Unique patterns of surface receptors, cytokine secretion, and immune functions distinguish T cells in the bone marrow from those in the periphery: impact.
Host-Derived CD8+ Dendritic Cells Protect Against Acute Graft-versus-Host Disease after Experimental Allogeneic Bone Marrow Transplantation  Michael Weber,
William H. D. Hallett, Weiqing Jing, William R. Drobyski, Bryon D
Secondary Lymphoid Organs Contribute to, but Are Not Required for the Induction of Graft-versus-Host Responses following Allogeneic Bone Marrow Transplantation:
Influence of Donor Microbiota on the Severity of Experimental Graft-versus-Host- Disease  Isao Tawara, Chen Liu, Hiroya Tamaki, Tomomi Toubai, Yaping Sun,
Host-Derived Interleukin-18 Differentially Impacts Regulatory and Conventional T Cell Expansion During Acute Graft-Versus-Host Disease  Robert Zeiser,
Extracorporeal Photopheresis Attenuates Murine Graft-versus-Host Disease via Bone Marrow–Derived Interleukin-10 and Preserves Responses to Dendritic Cell.
Volume 133, Issue 4, Pages (October 2007)
Th2 Cell Therapy of Established Acute Graft-Versus-Host Disease Requires IL-4 and IL- 10 and Is Abrogated by IL-2 or Host-Type Antigen-Presenting Cells 
Differential Effects of Gut-Homing Molecules CC Chemokine Receptor 9 and Integrin-β7 during Acute Graft-versus-Host Disease of the Liver  Alina Schreder,
Chronic graft-versus-host disease after granulocyte colony-stimulating factor-mobilized allogeneic stem cell transplantation: the role of donor T-cell.
by Yoshinobu Maeda, Pavan Reddy, Kathleen P
Thymic Selection by a Single MHC/Peptide Ligand
Apoptotic Donor Leukocytes Limit Mixed-Chimerism Induced by CD40-CD154 Blockade in Allogeneic Bone Marrow Transplantation  Jian-ming Li, John Gorechlad,
William H. D. Hallett, Weiqing Jing, William R. Drobyski, Bryon D
Functional divergence of antigen-specific T-lymphocyte responses in syngeneic graft- versus-host disease  Christopher J Thoburn, Yuji Miura, Emilie C Bright,
Induction of heme oxygenase-1 before conditioning results in improved survival and reduced graft-versus-host disease after experimental allogeneic bone.
Novel function for interleukin-7 in dendritic cell development
Mesenchymal Stem Cells (MSCs) Attenuate Cutaneous Sclerodermatous Graft-Versus- Host Disease (Scl-GVHD) through Inhibition of Immune Cell Infiltration.
Ex Vivo Rapamycin Generates Th1/Tc1 or Th2/Tc2 Effector T Cells With Enhanced In Vivo Function and Differential Sensitivity to Post-transplant Rapamycin.
LBH589 Enhances T Cell Activation In Vivo and Accelerates Graft-versus-Host Disease in Mice  Dapeng Wang, Cristina Iclozan, Chen Liu, Changqing Xia, Claudio.
Cytosine-Phosphorothionate-Guanine Oligodeoxynucleotides Exacerbates Hemophagocytosis by Inducing Tumor Necrosis Factor–Alpha Production in Mice after.
by Sheng F. Cai, Xuefang Cao, Anjum Hassan, Todd A
PreImplantation Factor Reduces Graft-versus-Host Disease by Regulating Immune Response and Lowering Oxidative Stress (Murine Model)  Yehudith Azar, Reut.
Blocking LFA-1 Activation with Lovastatin Prevents Graft-versus-Host Disease in Mouse Bone Marrow Transplantation  Yang Wang, Dan Li, Dan Jones, Roland.
IL-6 Blockade Attenuates the Development of Murine Sclerodermatous Chronic Graft- Versus-Host Disease  Doanh Le Huu, Takashi Matsushita, Guihua Jin, Yasuhito.
Evelyn C. Nieves, Tomomi Toubai, Daniel C
Volume 142, Issue 2, Pages e2 (February 2012)
Pharmacologic Expansion of Donor-Derived, Naturally Occurring CD4+Foxp3+ Regulatory T Cells Reduces Acute Graft-versus-Host Disease Lethality Without.
Absence of donor Th17 leads to augmented Th1 differentiation and exacerbated acute graft-versus-host disease by Tangsheng Yi, Dongchang Zhao, Chia-Lei.
Volume 18, Issue 5, Pages (May 2003)
Inhibition of Cathepsin S Reduces Allogeneic T Cell Priming but Not Graft-versus-Host Disease Against Minor Histocompatibility Antigens  Hisaki Fujii,
Depletion of Host CCR7+ Dendritic Cells Prevented Donor T Cell Tissue Tropism in Anti- CD3–Conditioned Recipients  Wei He, Jeremy J. Racine, Heather F.
Therapeutic Benefit of Bortezomib on Acute Graft-versus-Host Disease Is Tissue Specific and Is Associated with Interleukin-6 Levels  Chien-Chun Steven.
The Pentostatin Plus Cyclophosphamide Nonmyeloablative Regimen Induces Durable Host T Cell Functional Deficits and Prevents Murine Marrow Allograft Rejection 
Blocking Activator Protein 1 Activity in Donor Cells Reduces Severity of Acute Graft- Versus-Host Disease through Reciprocal Regulation of IL-17–Producing.
Volume 29, Issue 2, Pages (August 2008)
Essential Role of Interleukin-12/23p40 in the Development of Graft-versus-Host Disease in Mice  Yongxia Wu, David Bastian, Steven Schutt, Hung Nguyen,
Hydrodynamic Delivery of Human IL-15 cDNA Increases Murine Natural Killer Cell Recovery after Syngeneic Bone Marrow Transplantation  Isabel Barao, Maite.
T helper17 Cells Are Sufficient But Not Necessary to Induce Acute Graft-Versus-Host Disease  Cristina Iclozan, Yu Yu, Chen Liu, Yaming Liang, Tangsheng.
Lisa A. Palmer, George E. Sale, John I
Volume 132, Issue 1, Pages (January 2007)
Absence of Cutaneous TNFα-Producing CD4+ T Cells and TNFα may Allow for Fibrosis Rather than Epithelial Cytotoxicity in Murine Sclerodermatous Graft-Versus-Host.
Accelerated, but not conventional, radiotherapy of murine B-cell lymphoma induces potent T cell–mediated remissions by Suparna Dutt, Michelle B. Atallah,
Augmentation of antitumor immune responses after adoptive transfer of bone marrow derived from donors immunized with tumor lysate-pulsed dendritic cells 
IL-18, but Not IL-12, Induces Production of IFN-γ in the Immunosuppressive Environment of HPV16 E7 Transgenic Hyperplastic Skin  Christina Gosmann, Ian.
Host Basophils Are Dispensable for Induction of Donor T Helper 2 Cell Differentiation and Severity of Experimental Graft-versus-Host Disease  Isao Tawara,
Th2 Cell Therapy of Established Acute Graft-Versus-Host Disease Requires IL-4 and IL- 10 and Is Abrogated by IL-2 or Host-Type Antigen-Presenting Cells 
A Radio-Resistant Perforin-Expressing Lymphoid Population Controls Allogeneic T Cell Engraftment, Activation, and Onset of Graft-versus-Host Disease in.
Amotosalen-treated donor T cells have polyclonal antigen-specific long-term function without graft-versus-host disease after allogeneic bone marrow transplantation 
Tracking ex vivo-expanded CD4+CD25+ and CD8+CD25+ regulatory T cells after infusion to prevent donor lymphocyte infusion-induced lethal acute graft-versus-host.
Recipient B Cells Are Not Required for Graft-Versus-Host Disease Induction  Catherine Matte-Martone, Xiajian Wang, Britt Anderson, Dhanpat Jain, Anthony.
CD25 expression distinguishes functionally distinct alloreactive CD4+ CD134+ (OX40+) T-cell subsets in acute graft-versus-host disease  Philip R Streeter,
Volume 32, Issue 5, Pages (May 2010)
Cytokines and cytotoxic pathways in engraftment resistance to purified allogeneic hematopoietic stem cells  Christian Scheffold, Yolanda C. Scheffold,
Donor antigen-presenting cells regulate T-cell expansion and antitumor activity after allogeneic bone marrow transplantation  Jian-Ming Li, Edmund K.
Post-hematopoietic cell transplantation control of graft-versus-host disease by donor CD4+25+ T cells to allow an effective graft-versus-leukemia response 
Volume 18, Issue 3, Pages (March 2003)
Brile Chung, Eric Dudl, Akira Toyama, Lora Barsky, Kenneth I. Weinberg 
Staphylococcal enterotoxin A–activated regulatory T cells promote allergen-specific TH2 response to intratracheal allergen inoculation  Wei-ping Zeng,
Volume 16, Issue 4, Pages (April 2002)
Raimon Duran-Struuck, Isao Tawara, Kathi Lowler, Shawn G
Sibylle von Vietinghoff, Hui Ouyang, Klaus Ley  Kidney International 
Volume 19, Issue 1, Pages (July 2003)
Selective elimination of alloreactive donor T cells attenuates graft-versus-host disease and enhances T-cell reconstitution  Maria Gendelman, Maryam Yassai,
Induction of Lethal Graft-versus-Host Disease by Anti-CD137 Monoclonal Antibody in Mice Prone to Chronic Graft-versus-Host Disease  Wonyoung Kim, Juyang.
Roles of CD28, CTLA4, and Inducible Costimulator in Acute Graft-versus-Host Disease in Mice  Jun Li, Kenrick Semple, Woong-Kyung Suh, Chen Liu, Fangping.
Volume 4, Issue 5, Pages (May 1996)
Presentation transcript:

Host conditioning with total lymphoid irradiation and antithymocyte globulin prevents graft-versus-host disease: the role of CD1-reactive natural killer T cells  Fengshuo Lan, Defu Zeng, Masanori Higuchi, John P Higgins, Samuel Strober  Biology of Blood and Marrow Transplantation  Volume 9, Issue 6, Pages 355-363 (June 2003) DOI: 10.1016/S1083-8791(03)00108-3

Figure 1 Survival of Lewis rat hosts given BMTs from ACI rat donors. A, Hosts were given a single dose of 1050 cGy TBI without a cell infusion or with an intravenous injection of 100 × 106 ACI BM cells alone, ACI BM cells with 25 × 106ACI PBMC, or TBI combined with rabbit ATG and an injection of 100 × 106ACI BM cells and 25 × 106 PBMC (n = 6 in all groups). B, Hosts were given 2400 cGy TLI without a cell infusion, TLI with BM cells, or TLI with 100 × 106 BM cells and 25 × 106 PBMC (n = 6 in all groups). C, Hosts were given TLI and ATG without a cell infusion, TLI and ATG with 100 × 106 BM cells, or TLI and ATG with 100 × 106 BM cells and 25 × 106 PBMC (n = 5 in all groups). Data from 2 replicate experiments were combined and groups were set up concurrently for each experiment. Biology of Blood and Marrow Transplantation 2003 9, 355-363DOI: (10.1016/S1083-8791(03)00108-3)

Figure 2 Survival of Lewis rat hosts given BMT from ACI donors. A, Hosts were given TBI and100 × 106 BM cells without PBMC or with graded doses of PBMC (n = 5, 6 in all groups). B, Hosts were given TLI, ATG, and 100 × 106 BM cells with graded doses of PBMC (n = 5 for all groups). Data from 2 replicate experiments were combined. Experiments in Figures 1 and 2 were performed in the same time interval. Biology of Blood and Marrow Transplantation 2003 9, 355-363DOI: (10.1016/S1083-8791(03)00108-3)

Figure 3 Histopathologic examination of Lewis rat hosts given BMT from ACI donors. A, Microscopic section (× 400) of skin from a Lewis rat host given TBI, 100 × 106 BM cells and 0.1 × 106 PBMC. Skin samples were harvested 40 days after BMT. Arrow shows hyperplastic epidermis, arrow heads show necrotic keratinocytes, and asterisk shows subdermal blister. B, Microscopic section of large intestine of host in part A. Asterisk shows lymphocyte infiltrate surrounding crypts; arrow indicates lymphocyte infiltration into crypt. Plump mucin-containing glandular cells are rare. C, Microscopic section of skin 100 days after BMT from host given TLI, ATG, 100 × 106 BM cells, and 6.25 × 106 PBMC. Epidermis is 1 to 3 cells thick, and no dermal infiltrate is seen. D, Microscopic section of large intestine from host in part C. Plump mucin-containing glandular cells are abundant, and no lymphocytic infiltrate is observed. Biology of Blood and Marrow Transplantation 2003 9, 355-363DOI: (10.1016/S1083-8791(03)00108-3)

Figure 4 Chimerism in Lewis hosts given BMT from ACI donors: Two-color flow cytometric analysis of PBMC from a Lewis host given either TBI and 100 × 106 ACI BM cells or TLI, ATG, and 100 × 106 ACI BM cells with or without 25 × 106 ACI PBMC. Host cells were obtained at 100 days, and stained for CD3, pan B, or granulocyte and macrophage markers, and versus RT1A (a,b) (donor type) markers. Boxes on left enclose host cells, and boxes on right enclose donor cells. Percentages in each box are shown. Biology of Blood and Marrow Transplantation 2003 9, 355-363DOI: (10.1016/S1083-8791(03)00108-3)

Figure 5 Wild-type and NK T-cell deficient CD1−/− BALB/c hosts compared for splenic T cell subsets and for survival after BMT from C57 BL/6 donors. A, Wild-type or CD1−/− BALB/c mice were given TLI and 3 injections of ATS or no treatment. Immediately after TLI/ATS conditioning, spleen cells were stained with anti-TCRαβ monoclonal antibodies versus CD1 tetramers loaded with α galactosyl ceramide. Panels show tetramer versus TCRαβ staining of gated TCRαβ+ T cells. Boxes enclose TCRαβ+ tetramer+ cells. Background staining of TCRαβ cells was approximately 1.5%. B, Control wild-type BALB/c hosts were conditioned with either TBI (800 cGy) alone or TBI and 3 injections of ATS (days −12, −8, −6). Experimental wild-type or CD1−/− hosts were conditioned with TLI (17 doses of 240 cGy each) and ATS (days −12, −8, −6). All hosts were given 3 × 106 C57BL/6 BM cells and 0.5 × 106C57BL/6 PBMC within 24 hours after the completion of TLI or TBI. Survival is shown for 6 to 10 hosts in each group. Biology of Blood and Marrow Transplantation 2003 9, 355-363DOI: (10.1016/S1083-8791(03)00108-3)

Figure 6 Cytokine secretion patterns of donor and host T cells in BALB/c mixed chimeras. Wild-type BALB/c hosts were given TLI, ATS, C57BL/6 BMT (3 × 106 BM cells and 0.5 × 106 PBMC), and observed for at least 100 days as in Figure 5. Spleen cells from 3 surviving hosts were pooled, stained for TCRαβ, H-2Kb (donor-type) and H-2Kd (host type) surface markers, and analyzed using 3-color flow cytometric analysis. Gated TCRαβ+ T cells (enclosed in box in left panel) were analyzed for H-2Kb versus H-2Kd subsets (enclosed in boxes in middle panel). H-2Kb and H-2Kd-positive cells were sorted, and 0.2 × 106 cells per well were stimulated in vitro with phorbol myristate acetate and calcium ionophore. After 48 hours, culture supernatants were assayed for the concentration of IL-4 and IFN-γ by the ELISA technique (right panel). Control cultures used sorted splenic TCRαβ+ T cells from wild-type C57BL/6 (WT B6) or BALB/c (WT BALB/c) untreated mice. Bars show the mean concentrations of 5 individual cultures and brackets show the standard errors. One of 2 replicate experiments is shown in which pooled cells from a total of 6 mice were analyzed. Biology of Blood and Marrow Transplantation 2003 9, 355-363DOI: (10.1016/S1083-8791(03)00108-3)